awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34233273-633D2029-5C7A-436F-B660-57774E6BFE3F
Q34233273-633D2029-5C7A-436F-B660-57774E6BFE3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34233273-633D2029-5C7A-436F-B660-57774E6BFE3F
Overcoming platinum resistance in ovarian carcinoma.
P2860
Q34233273-633D2029-5C7A-436F-B660-57774E6BFE3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34233273-633D2029-5C7A-436F-B660-57774E6BFE3F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
059e142b37f6e4318fa56a5c7b235e8c80c627e0
P2860
Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer.